Cystathionase mediates senescence evasion in melanocytes and melanoma cells
- 28 January 2013
- journal article
- Published by Springer Nature in Oncogene
- Vol. 33 (6) , 771-782
Abstract
The development of malignant melanoma is a highly complex process, which is still poorly understood. A majority of human melanomas are found to express a few oncogenic proteins, such as mutant RAS and BRAF variants. However, these oncogenes are also found in nevi, and it is now a well-accepted fact that their expression alone leads to senescence. This renders the understanding of senescence escape mechanisms an important point to understand tumor development. Here, we approached the question of senescence evasion by expressing the transcription factor v-myc myelocytomatosis viral oncogene homolog (c-MYC), which is known to act synergistically with many oncogenes, in melanocytes. We observed that MYC drives the evasion of reactive-oxygen stress-induced melanocyte senescence, caused by activated receptor tyrosine kinase signaling. Conversely, MIZ1, the growth suppressing interaction partner of MYC, is involved in mediating melanocyte senescence. Both, MYC overexpression and Miz1 knockdown led to a strong reduction of endogenous reactive-oxygen species (ROS), DNA damage and senescence. We identified the cystathionase (CTH) gene product as mediator of the ROS-related MYC and MIZ1 effects. Blocking CTH enzymatic activity in MYC-overexpressing and Miz1 knockdown cells increased intracellular stress and senescence. Importantly, pharmacological inhibition of CTH in human melanoma cells also reconstituted senescence in the majority of cell lines, and CTH knockdown reduced tumorigenic effects such as proliferation, H2O2 resistance and soft agar growth. Thus, we identified CTH as new MYC target gene with an important function in senescence evasion.Keywords
This publication has 63 references indexed in Scilit:
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Oncogenic Mutations inGNAQOccur Early in Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2008
- C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cellsOncogene, 2008
- Myc Down-regulation as a Mechanism to Activate the Rb Pathway in STAT5A-induced SenescenceJournal of Biological Chemistry, 2007
- Differential oncogenic potential of activated RAS isoforms in melanocytesOncogene, 2007
- Myc Down-Regulation Sensitizes Melanoma Cells to Radiotherapy by Inhibiting MLH1 and MSH2 Mismatch Repair ProteinsClinical Cancer Research, 2005
- The relation between c-myc expression and interferon sensitivity in uveal melanomaBritish Journal of Ophthalmology, 2004
- C-Myc Down-Regulation Increases Susceptibility to Cisplatin through Reactive Oxygen Species-Mediated Apoptosis in M14 Human Melanoma CellsMolecular Pharmacology, 2001
- Influence of Increased c-Myc Expression on the Growth Characteristics of Human MelanomaJournal of Investigative Dermatology, 1999
- Complementation of Defective Colony-Stimulating Factor 1 Receptor Signaling and Mitogenesis by Raf and v-SrcMolecular and Cellular Biology, 1999